$40.7 Million is the total value of Valliance Asset Management Ltd's 3 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 50.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Buy | PINDUODUO INCnote 12/0 | $22,700,000 | +144.1% | 25,000,000 | +150.0% | 55.81% | +495.3% | |
SMIHU | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $9,995,000 | -0.5% | 1,000,000 | 0.0% | 24.57% | +142.6% | |
HHLAU | HH&L ACQUISITION COunit 99/99/9999 | $7,980,000 | +0.5% | 800,000 | 0.0% | 19.62% | +145.0% | |
Exit | BILIBILI INCnote 1.250% 6/1 | $0 | – | -10,200,000 | -100.0% | -18.43% | – | |
SE | Exit | SEA LTDsponsord ads | $0 | – | -72,800 | -100.0% | -23.39% | – |
Exit | SEA LTDnote 0.250% 9/1 | $0 | – | -30,000,000 | -100.0% | -30.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-01-28
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HH&L ACQUISITION CO | 8 | Q4 2022 | 100.0% |
SUMMIT HEALTHCRE ACQUISTN CO | 7 | Q4 2022 | 55.2% |
PINDUODUO INC | 4 | Q4 2021 | 55.8% |
TAIWAN SEMICONDUCTOR MFG LTD | 3 | Q2 2023 | 63.9% |
YS BIOPHARMA CO LTD | 3 | Q3 2023 | 35.4% |
YS BIOPHARMA CO LTD | 3 | Q3 2023 | 0.6% |
HH&L ACQUISITION CO | 3 | Q3 2023 | 0.1% |
ALIBABA GROUP HLDG LTD | 2 | Q1 2023 | 54.4% |
SEA LTD | 2 | Q3 2021 | 42.3% |
NVIDIA CORPORATION | 2 | Q3 2023 | 23.0% |
View Valliance Asset Management Ltd's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-01-31 |
13F-HR | 2023-10-27 |
13F-HR | 2023-07-26 |
13F-HR | 2023-05-10 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-10 |
13F-HR | 2022-04-25 |
13F-HR | 2022-01-28 |
13F-HR | 2021-10-27 |
View Valliance Asset Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.